Cargando…

The added value of centres of expertise for rare disease patients in Europe

Detalles Bibliográficos
Autores principales:	Kole, Anna A, le Cam, Yann
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958392/ http://dx.doi.org/10.1186/1750-1172-5-S1-O4

Ejemplares similares

Perspective having a Centre of Expertise that covers more than one rare disease
por: Ostergaard, John R
Publicado: (2014)

Building centres of expertise according to the Dutch model?
por: Gabreëls, Fons JM, et al.
Publicado: (2010)

DYSCERNE: a European Network of Centres of Expertise for Dysmorphology
por: Chrzanowska, Krystyna, et al.
Publicado: (2010)

The Swedish rare disease information database and the Swedish information centre for rare diseases
por: Greek-Winald, Christina, et al.
Publicado: (2010)

The present situation of Rare Diseases in Central/Eastern Europe? The role of patient organisations
por: Pogany, Gabor
Publicado: (2010)

Video adjudication in clinical trials: enabling distribution of expertise and accurate scoring
por: Stevenson, Alan, et al.
Publicado: (2015)

A systematic review of the use of an expertise-based randomised trial design
por: Cook, Jonathan, et al.
Publicado: (2015)

Value of saliva testing when added to questionnaire screening for unhealthy drug use
por: Saade, H John, et al.
Publicado: (2015)

Can we recruit to expertise trials? Experience from the total or partial knee arthroplasty trial (TOPKAT)
por: Davies, Loretta, et al.
Publicado: (2013)

RARE-Bestpractices: a platform for sharing best practices for the management of rare diseases
por: Taruscio, D, et al.
Publicado: (2014)

French experience with rare diseases plans
por: Le Henanff, Guillaume, et al.
Publicado: (2010)

Patient involvement and empowerment through the NPRD (Eastern Europe)
por: Dan, Dorica
Publicado: (2010)

Applications of the PMO platform to genetic diseases
por: Kole, Ryszard
Publicado: (2015)

Mapping and modeling Dirofilaria infections in Europe
por: Rinaldi, L, et al.
Publicado: (2014)

Contribution of rare disease patient organisations to medical education
por: von Gizycki, Rainald
Publicado: (2010)

Patient innovation under rare diseases and chronic needs
por: Oliveira, Pedro, et al.
Publicado: (2014)

State of the art of services in Europe: where are the problems?
por: Aymé, Ségolène
Publicado: (2010)

Scope of centres of expertise for rare diseases in European countries where they exist
por: Rodwell, Charlotte, et al.
Publicado: (2012)

Ten years of MRSA surveillance in Switzerland: similarities and differences with Europe
por: Olearo, F, et al.
Publicado: (2015)

Determinants for research on rare diseases
por: Palau, Francesc
Publicado: (2010)

Ageing in rare, chronic diseases
por: Smit, Cees
Publicado: (2010)

SHARE – workpackage 5: development of best practices of diagnosis and treatment for paediatric rheumatic diseases throughout Europe
por: Vastert, Sebastiaan, et al.
Publicado: (2014)

Evidence for Env-V2 sieve effect in breakthrough SIV (MAC251) infections in rhesus monkeys vaccinated with Ad26/MVA and MVA/Ad26 constructs
por: Sina, S, et al.
Publicado: (2012)

The Biopontis Alliance Rare Disease Foundation (BARDF) – an innovative model for early stage rare disease therapy financing and development
por: Tambuyzer, Erik T, et al.
Publicado: (2014)

OrphanAnesthesia – anesthesia recommendations for patients suffering from rare diseases
por: Münster, Tino
Publicado: (2014)

S8.5c MLST genotyping and phylogenetics of AD-hybrids
por: Cogliati, Massimo, et al.
Publicado: (2022)

Which support from the French Foundation of rare disease towards clinical trial set up in rare diseases?
por: Ravagnan, Luigi
Publicado: (2015)

Preliminary study of regionalised centre-of-pressure analysis in patients with juvenile idiopathic arthritis
por: Hendry, Gordon J, et al.
Publicado: (2012)

DPD Scintigraphy for diagnosis of amyloidosis in 1191 patients– a single centre experience
por: Hutt, David, et al.
Publicado: (2015)

A multiclade DNA/Ad vaccines for AIDS: the present and next generation
por: Nabel, Gary J
Publicado: (2006)

Recommendations for the development of national plans for rare diseases
por: Van der Zeijden, Albert, et al.
Publicado: (2010)

Epidemiology and models of care for mentally disordered prisoners in Europe – the EUPRIS study
por: Salize, Hans Joachim, et al.
Publicado: (2007)

How to code rare diseases with international terminologies?
por: Rath, Ana, et al.
Publicado: (2014)

National Rare Disease Registries: overview from Spain
por: de la Paz, M Posada, et al.
Publicado: (2014)

P147 Fungal osteomyelitis in patients with chronic granulomatous disease: a case series from a tertiary care medical centre.
por: Sachdev, Janya, et al.
Publicado: (2022)

Trends of cardiothoracic trauma at new trauma centre
por: Mhandu, P, et al.
Publicado: (2013)

Evaluation of Centres: the French experience since 2009
por: Sarnacki, S
Publicado: (2014)

Direct aortic approach for TAVI: a single centre experience
por: Amrane, H, et al.
Publicado: (2013)

Why we should have more collaboration on HTA in Europe: the example of sofosbuvir
por: Schelleman, Hedi, et al.
Publicado: (2015)

The German plan for rare diseases: a development in progress
por: Graf von der Schulenburg, Johann Mathias
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_goa9j327sf2jrafjkapi6fhamu